We observed that the average amount of DNA isolated (295 ng) was lower in the group (n = 15) where two or more assays failed [as compared to the group without failing assays (n = 102, 2973 ng)].
Samples from 100 participants were excluded from the analysis due to the results failing our assay quality control criteria of the lymphocyte subset sum being outside of the 95% 105% range and/or the difference between replicate CD3 results being greater than 2%.
As a result of the lack of authentic reference samples, often only the %API is used for interpretation, which is insufficient to allow confident classification as counterfeit or substandard and some of those samples failing chemical assays may have been counterfeit rather than substandard.
The iPLEX20SNP assay provided complete 20-SNP profiles for 471/506 isolates (type-ability = 93.1%) of which there were 147 distinct 20-SNP profiles; 35 isolates failed to provide complete 20-SNP profiles due to the iPLEX20SNP assay failing to characterise one or more SNPs (Additional file 3: Table S3).
Similarly, the nuisance parameter z j (probability of an assay failing for a individual at SNP j) is also estimated via EM in tandem with the model parameters and A allele frequency, with initial values being proposed from the Beta(1,20) distribution.
A subset of males never initiated any interaction with females during the courtship assays, failing to score greater than "2" (movement) on the MMP scale at any point of observation over the duration of the assay.
Assays failing to multiplex were genotyped using the TaqMan 5' exonuclease [Applied Biosystems (ABI), Foster City, CA, USA] with primers from ABI using radioactive labeled probes detected with ABI PRISM 7900 Sequence Detector System [ 46].
Since the test is designed to be run in local molecular pathology labs, all quality thresholds are applied automatically to the data by embedded software; any failing metric causes an assay failure notice which prevents output of a Prosigna assay result.
For many substances that produce cancer in laboratory animal studies, even for those that may cause point mutations in genotoxicity assays, assessors are failing to objectively describe the evidence for alternatives to linear low-dose extrapolation (Boobis et al., 2009; Cohen & Arnold, 2011; Swenberg et al., 2011).
Aulicino et al 36 evaluated 71 perinatally infected children and adolescents in Argentina who were failing their current regimen with VL assays and resistance testing between the years of 2006 and 2008.
